Nebivolol tablets recalled due to cross-contamination with other products
Glenmark Pharmaceuticals is recalling 672 bottles of Nebivolol 20 mg tablets nationwide due to cross contamination with other products. The affected lot (17240988) expires 05/31/2026.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class III recall with no reported illnesses or injuries. The contamination hazard is precautionary and unspecified, consistent with low-risk contamination voluntary recalls typical of Class III classifications.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling 672 bottles of Nebivolol 20 mg tablets (NDC 42291-874-90) due to cross contamination with other products. The affected lot number is 17240988, with an expiration date of 05/31/2026.
The product was distributed nationwide throughout the United States. Consumers who have this medication should contact their pharmacist or healthcare provider with questions.
The recalled product
- Product
- NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)
- Brand
- NEBIVOLOL
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug
- Hazard
- cross-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 17240988
- Exp. 05/31/2026
UPCs (3)
- 0342291872905
- 0342291874909
- 0342291873902
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NEBIVOLOL
- HighPrescription drug recall: Aurobindo Nebivolol tablets contain excess nitrosamine impurity
FDA (Drugs) · 2024-12-25
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27